Response 13402096

Back to Response listing

Part 1: Proposed scope of TGO 110

4. Do you think that export only vaporiser nicotine should be required to comply with TGO 110?

Please select one item
Radio button: Unticked Yes
Radio button: Ticked No

5. Why/Why not?

Please give your reasons
It is working perfectly well as it is.

6. Do you think clinical trial products should be required to comply with TGO 110?

Please select one item
Radio button: Unticked Yes
Radio button: Ticked No

7. Why/Why not?

Please give your reasons
It is working perfectly well as it is.

8. Do you think products that are the subject of an FDA PMTA marketing order, or that are supplied in the UK, EU, Canada, NZ and/or another country in accordance with the relevant requirements of that country, should be deemed to comply with TGO 110 (in whole or in part)?

Please select one item
Radio button: Ticked Yes
Radio button: Unticked No

9. Why/Why not?

Please give your reasons
I have been using them for over 3 years and they allowed me to quit smoking after 40 years. I consider the products I use to be perfectly safe.

10. Would any of these options, particularly the TGA’s proposed option, have an impact on you? How?

How does this impact you?
If they restrict my ability to use nicotine vaping products it is highly likely that I will again take up smoking.

11. Do you have any other comments about the products covered by or excluded from draft TGO 110?

Do you have any other comments?
No

Part 2: Labelling – Ingredient Lists

12. Which option (whether listed above or not) do you prefer? Why?

Which option do you prefer and why?
4. Everything else consumed requires a list of ingredients. Extra safety measure that would ensure quality compliance.

13. Would any of these options, particularly the TGA’s proposed option, have an impact on you? How?

Would any of these options impact you and how?
No.

Part 2: Labelling – Nicotine Concentration

14. Which option (whether listed above or not) do you prefer? Why?

Which option do you prefer and why?
4, again quality control.

15. Would any of these options, particularly the TGA’s proposed option, have an impact on you? How?

Would any of these options impact you and how?
No.

Part 2: Labelling – Warning Statements

16. Which option (whether listed above or not) do you prefer? Why?

Which option do you prefer and why?
3 for simplicity.

17. Would any of these options, particularly the TGA’s proposed option, have an impact on you? How?

Would any of these options impact you and how?
No

Part 2: Ingredients – Prohibiting Certain Ingredients

18. Which option (whether listed above or not) do you prefer? Why?

Which option do you prefer and why?
1. Happy to follow health guidelines on dangerous additives.

19. Would any of these options, particularly the TGA’s proposed option, have an impact on you? How?

Would any of these options impact you and how?
No.

Part 2: Ingredients - Flavours

20. Which option (whether listed above or not) do you prefer? Why?

Which option do you prefer and why?
3. Adults choice.

21. Would any of these options, particularly the TGA’s proposed option, have an impact on you? How?

Would any of these options impact you and how?
No. I prefer tobacco flavours in any case.

Part 2: Packaging – Child-Resistant Packaging

22. Which option (whether listed above or not) do you prefer? Why?

Which option do you prefer and why?
2. Happy to keep it out of the hands of minors.

23. Would any of these options, particularly the TGA’s proposed option, have an impact on you? How?

Would any of these options impact you and how?
No.

Part 2: Packaging –Tamper-proof/evident Packaging

24. Which option (whether listed above or not) do you prefer? Why?

Which option do you prefer and why?
1. Safety, like any other consumer product.

25. Would any of these options, particularly the TGA’s proposed option, have an impact on you? How?

Would any of these options impact you and how?
No.

Part 2: Nicotine concentration

26. Which option (whether listed above or not) do you prefer? Why?

Which option do you prefer and why?
2. Adult choice.

27. Would any of these options, particularly the TGA’s proposed option, have an impact on you? How?

Would any of these options impact you and how?
No.

Part 2: Volume

28. Which option (whether listed above or not) do you prefer? Why?

Which option do you prefer and why?
3. Adult choice.

29. Would any of these options, particularly the TGA’s proposed option, have an impact on you? How?

Would any of these options impact you and how?
No.

Part 2: Other Questions/ Comments

30. Are there any other potential minimum requirements for unapproved vaporiser nicotine products the TGA should consider including in TGO 110?

Other minimum requirements TGA should consider
No.

31. Would you like to be consulted on any draft guidance prepared for TGO 110?

Would you like to be consulted on any draft guidance prepared for TGO 110?
Yes.

Part 3: Related Matters

32. Which option (whether listed above or not) do you prefer? Why?

Which option do you prefer and why?
4. Adult choice.

33. Would any of these options, particularly the TGA’s proposed option, have an impact on you? How?

Would any of these options impact you and how?
No.

Part 3: Compounding

34. Do you have any comments on the application of TGO 110 to compounded vaporiser nicotine products?

Comments on the applcation of TGO 110
No.

Consent to publish

35. Do you consent to your answers being published

Please select one item
(Required)
Radio button: Ticked Yes
Radio button: Unticked No